SMS PHARMA share price has zoomed 13% and is presently trading at Rs 381.3.
Meanwhile, the BSE HEALTHCARE index is at 44,174.7 (up 0.8%).
Among the top gainers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (up 2.5%) and Procter & Gamble Health (up 2.4%).
SYNGENE INTERNATIONAL (down 1.2%) and ERIS LIFESCIENCES (down 1.0%) are among the top losers today.
Over the last one year, SMS PHARMA has moved up from Rs 127.2 to Rs 381.3, registering a gain of Rs 254.2 (up 199.9%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,436.8 to 44,174.7, registering a gain of 55.3% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 134.5%), Jubilant Pharmova (up 129.2%) and GRANULES INDIA (up 121.6%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 81,978.9 (up 0.1%).
The top gainers among the BSE Sensex today are Asian Paints (up 0.8%) and Bajaj Finance (up 0.8%). The most traded stocks in the BSE Sensex are Tata Motors and Tata Steel.
In the meantime, NSE Nifty is at 25,062.1 (up 0.1%). Bajaj Auto and Dr. Reddys are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 67,127.1 to 81,978.9, registering a gain of 14,851.9 points (up 22.1%).
SMS PHARMA net profit grew 85.9% YoY to Rs 164 million for the quarter ended June 2024, compared to a profit of Rs 88 million a year ago. Net sales rose 21.5% to Rs 1,645 million during the period as against Rs 1,353 million in April-June 2023.
For the year ended March 2023, SMS PHARMA reported 94.3% decrease in net profit to Rs 39 million compared to net profit of Rs 679 million during FY22. Revenue of the company grew 1.2% to Rs 4,914 million during FY23.
The current Price to earnings ratio of SMS PHARMA, based on rolling 12 month earnings, stands at 56.9.
Equitymaster requests your view! Post a comment on "SMS PHARMA Gains 13%; BSE HEALTHCARE Index Up 0.8%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!